Table 1.

Selected reports of intracameral antibiotics in cataract surgery

Series	n	Nation	Antibiotics	Rate without intracameral antibiotics (%)	Rate with intracameral antibiotics (%)	P-value
ESCRS10,*	16,603	Multiple	Cefuroxime	0.18–0.23	0.025–0.050	0.005
Yu-Wai-Man et al12	36,743	UK	Cefuroxime	0.14	0.046	0.0068
Garat et al13	18,579	Spain	Cefazolin	0.39	0.032	<0.0000001
Barreau et al16	5,115	France	Cefuroxime	1.24	0.044	<0.0001
Romero-Aroca et al14	25,001	Spain	Cefazolin	0.63	0.05	<0.001
Tan et al17	50,177	Singapore	Cefazolin	0.064	0.01	<0.001
Friling et al20	464,996	Sweden	Cefuroxime	0.39	0.027	<0.001
Matsuura et al21	34,752	Japan	Moxifloxacin	0.051	0.015	0.037
Shorstein et al18	16,264	USA	Multiple	0.31	0.014–0.14	NR
Rodriguez-Caravaca et al15	19,463	Spain	Cefuroxime	0.59	0.039	<0.05
Beselga et al22	15,689	Portugal	Cefuroxime	0.26	0	<0.05
Rudnisky et al25,**	75,318	Canada	Multiple	0.03	0.03	0.90
Herrinton et al19	315,246	USA	Multiple	0.07–0.14	0.044	NR
Katz et al24	56,094	Israel	Cefuroxime	0.083	0.034	0.03
Rahman and Murphy23	16,975	Ireland	Cefuroxime	0.49	0.06	<0.0001
Sharma et al26,**	15,122	India	Cefuroxime	0.16	0.11	0.38

Notes:

^*Randomized clinical trial.

^**Series reporting no significant difference in endophthalmitis rates.

Abbreviations: ESCRS, European Society of Cataract and Refractive Surgeons; NR, not reported.